Vaccinations in children with cancer

Susanna Esposito, Valerio Cecinati, Letizia Brescia, Nicola Principi

Research output: Contribution to journalArticlepeer-review


Children with cancer may be immunocompromised as a result of their primary underlying disease and/or the use of prolonged and intensive chemotherapy administered with or without irradiation. The damage to the immune system varies with the age of the patient, the type of cancer, and the intensity of the chemotherapy used to treat it. This review analyses the data regarding the immunogenicity, efficacy, safety and tolerability of the vaccines usually recommended in the first years of life in order to help pediatricians choose the best immunisation programme against vaccine-preventable disease in children with cancer receiving standard-dose chemotherapy. Areas for future research are highlighted because new data are required to be able to draw up evidence-based recommendations that will ensure adequate protection against infectious diseases in such high-risk children.

Original languageEnglish
Pages (from-to)3278-3284
Number of pages7
Issue number19
Publication statusPublished - Apr 26 2010


  • Cancer
  • Children
  • Prevention
  • Vaccination
  • Vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine


Dive into the research topics of 'Vaccinations in children with cancer'. Together they form a unique fingerprint.

Cite this